APO RESEARCH · REPORT
Total Artificial Heart
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Product & engineering
Understand the product.
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Selected research
Industry Growth & Trends
Global Total Artificial Heart Industry Growth and Trends Forecast to 2032
Market perspective
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Total Artificial Heart market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Total Artificial Heart market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Total Artificial Heart market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Total Artificial Heart.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Total Artificial Heart market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Total Artificial Heart Market by Company
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Total Artificial Heart Segment by Type
SynCardia
Others
Total Artificial Heart Segment by Application
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
Total Artificial Heart Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Total Artificial Heart market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Total Artificial Heart and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Total Artificial Heart.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Total Artificial Heart in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- SynCardia
- Others
Applications
- Dilated Cardiomyopathy
- Ischemic Cardiomyopathy
- Others
Companies covered
- BiVACOR
- SynCardia
- Jarvik Heart
- CARMAT
- AbioMed
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Total Artificial Heart Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Total Artificial Heart Sales Estimates and Forecasts (2021-2032)
- 1.3 Total Artificial Heart Market by Type
- 1.3.1 SynCardia
- 1.3.2 Others
- 1.4 Global Total Artificial Heart Market Size by Type
- 1.4.1 Global Total Artificial Heart Market Size Overview by Type (2021-2032)
- 1.4.2 Global Total Artificial Heart Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Total Artificial Heart Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Total Artificial Heart Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Total Artificial Heart Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Total Artificial Heart Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Total Artificial Heart Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Total Artificial Heart Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Total Artificial Heart Industry Trends
- 2.2 Total Artificial Heart Industry Drivers
- 2.3 Total Artificial Heart Industry Opportunities and Challenges
- 2.4 Total Artificial Heart Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Total Artificial Heart Revenue (2021-2026)
- 3.2 Global Top Players by Total Artificial Heart Sales (2021-2026)
- 3.3 Global Top Players by Total Artificial Heart Price (2021-2026)
- 3.4 Global Total Artificial Heart Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Total Artificial Heart Major Company Production Sites & Headquarters
- 3.6 Global Total Artificial Heart Company, Product Type & Application
- 3.7 Global Total Artificial Heart Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Total Artificial Heart Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Total Artificial Heart Players Market Share by Revenue in 2025
- 3.8.3 2025 Total Artificial Heart Tier 1, Tier 2, and Tier 3
4 Total Artificial Heart Regional Status and Outlook
- 4.1 Global Total Artificial Heart Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Total Artificial Heart Historic Market Size by Region
- 4.2.1 Global Total Artificial Heart Sales in Volume by Region (2021-2026)
- 4.2.2 Global Total Artificial Heart Sales in Value by Region (2021-2026)
- 4.2.3 Global Total Artificial Heart Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Total Artificial Heart Forecasted Market Size by Region
- 4.3.1 Global Total Artificial Heart Sales in Volume by Region (2027-2032)
- 4.3.2 Global Total Artificial Heart Sales in Value by Region (2027-2032)
- 4.3.3 Global Total Artificial Heart Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Total Artificial Heart by Application
- 5.1 Total Artificial Heart Market by Application
- 5.1.1 Dilated Cardiomyopathy
- 5.1.2 Ischemic Cardiomyopathy
- 5.1.3 Others
- 5.2 Global Total Artificial Heart Market Size by Application
- 5.2.1 Global Total Artificial Heart Market Size Overview by Application (2021-2032)
- 5.2.2 Global Total Artificial Heart Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Total Artificial Heart Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Total Artificial Heart Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Total Artificial Heart Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Total Artificial Heart Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Total Artificial Heart Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Total Artificial Heart Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 BiVACOR
- 6.1.1 BiVACOR Company Information
- 6.1.2 BiVACOR Business Overview
- 6.1.3 BiVACOR Total Artificial Heart Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 BiVACOR Total Artificial Heart Product Portfolio
- 6.1.5 BiVACOR Recent Developments
- 6.2 SynCardia
- 6.2.1 SynCardia Company Information
- 6.2.2 SynCardia Business Overview
- 6.2.3 SynCardia Total Artificial Heart Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 SynCardia Total Artificial Heart Product Portfolio
- 6.2.5 SynCardia Recent Developments
- 6.3 Jarvik Heart
- 6.3.1 Jarvik Heart Company Information
- 6.3.2 Jarvik Heart Business Overview
- 6.3.3 Jarvik Heart Total Artificial Heart Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Jarvik Heart Total Artificial Heart Product Portfolio
- 6.3.5 Jarvik Heart Recent Developments
- 6.4 CARMAT
- 6.4.1 CARMAT Company Information
- 6.4.2 CARMAT Business Overview
- 6.4.3 CARMAT Total Artificial Heart Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 CARMAT Total Artificial Heart Product Portfolio
- 6.4.5 CARMAT Recent Developments
- 6.5 AbioMed
- 6.5.1 AbioMed Company Information
- 6.5.2 AbioMed Business Overview
- 6.5.3 AbioMed Total Artificial Heart Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 AbioMed Total Artificial Heart Product Portfolio
- 6.5.5 AbioMed Recent Developments
7 North America by Country
- 7.1 North America Total Artificial Heart Sales by Country
- 7.1.1 North America Total Artificial Heart Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Total Artificial Heart Sales by Country (2021-2026)
- 7.1.3 North America Total Artificial Heart Sales Forecast by Country (2027-2032)
- 7.2 North America Total Artificial Heart Market Size by Country
- 7.2.1 North America Total Artificial Heart Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Total Artificial Heart Market Size by Country (2021-2026)
- 7.2.3 North America Total Artificial Heart Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Total Artificial Heart Sales by Country
- 8.1.1 Europe Total Artificial Heart Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Total Artificial Heart Sales by Country (2021-2026)
- 8.1.3 Europe Total Artificial Heart Sales Forecast by Country (2027-2032)
- 8.2 Europe Total Artificial Heart Market Size by Country
- 8.2.1 Europe Total Artificial Heart Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Total Artificial Heart Market Size by Country (2021-2026)
- 8.2.3 Europe Total Artificial Heart Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Total Artificial Heart Sales by Country
- 9.1.1 Asia-Pacific Total Artificial Heart Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Total Artificial Heart Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Total Artificial Heart Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Total Artificial Heart Market Size by Country
- 9.2.1 Asia-Pacific Total Artificial Heart Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Total Artificial Heart Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Total Artificial Heart Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Total Artificial Heart Sales by Country
- 10.1.1 South America Total Artificial Heart Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Total Artificial Heart Sales by Country (2021-2026)
- 10.1.3 South America Total Artificial Heart Sales Forecast by Country (2027-2032)
- 10.2 South America Total Artificial Heart Market Size by Country
- 10.2.1 South America Total Artificial Heart Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Total Artificial Heart Market Size by Country (2021-2026)
- 10.2.3 South America Total Artificial Heart Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Total Artificial Heart Sales by Country
- 11.1.1 Middle East and Africa Total Artificial Heart Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Total Artificial Heart Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Total Artificial Heart Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Total Artificial Heart Market Size by Country
- 11.2.1 Middle East and Africa Total Artificial Heart Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Total Artificial Heart Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Total Artificial Heart Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Total Artificial Heart Value Chain Analysis
- 12.1.1 Total Artificial Heart Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Total Artificial Heart Production Mode & Process
- 12.2 Total Artificial Heart Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Total Artificial Heart Distributors
- 12.2.3 Total Artificial Heart Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst